Cargando…
JAK ANTAGONISTS AND IL-6 INHIBITORS FOR MANAGEMENT OF SARS-COV-2 INFECTION: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Autores principales: | KHANAM, RUKHSAAR, BHAGAVAN, MONICA, SHAH, AASHKA, NAIK, ANANT |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548709/ http://dx.doi.org/10.1016/j.chest.2022.08.463 |
Ejemplares similares
-
COVID-19 PNEUMONIA COMPLICATED BY CMV PNEUMONITIS FOLLOWING TREATMENT WITH AN IL-6 INHIBITOR
por: PANDIAN, ELIZABETH, et al.
Publicado: (2021) -
THE ASSOCIATION OF IL-6 VALUE, INTERLEUKIN INHIBITORS, AND OUTCOMES OF PATIENTS WITH COVID-19 IN NEW YORK CITY
por: Obata, Reiichiro, et al.
Publicado: (2020) -
RETROSPECTIVE ANALYSIS OF PULMONARY FUNCTION DURING THE POSTACUTE SEQUELAE OF SARS-COV-2 INFECTION
por: DIPOLLINA, CHRISTOPHER, et al.
Publicado: (2022) -
COLCHICINE TREATMENT IN SARS-COV-2 INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: BERAN BERAN, AZIZULLAH, et al.
Publicado: (2021) -
SARS-COV-2 INFECTION WITH RITUXIMAB THERAPY
por: AUGENSTEIN, CHERYL, et al.
Publicado: (2022)